MY119567A - Matrix metalloproteinase levels as indicators of endometrial cancer - Google Patents
Matrix metalloproteinase levels as indicators of endometrial cancerInfo
- Publication number
- MY119567A MY119567A MYPI98001218A MYPI9801218A MY119567A MY 119567 A MY119567 A MY 119567A MY PI98001218 A MYPI98001218 A MY PI98001218A MY PI9801218 A MYPI9801218 A MY PI9801218A MY 119567 A MY119567 A MY 119567A
- Authority
- MY
- Malaysia
- Prior art keywords
- matrix metalloproteinase
- endometrial cancer
- indicators
- levels
- metalloproteinase levels
- Prior art date
Links
- 206010014733 Endometrial cancer Diseases 0.000 title abstract 2
- 206010014759 Endometrial neoplasm Diseases 0.000 title abstract 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 title 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 102000000424 Matrix Metalloproteinase 2 Human genes 0.000 abstract 1
- 108010016165 Matrix Metalloproteinase 2 Proteins 0.000 abstract 1
- 102000001776 Matrix metalloproteinase-9 Human genes 0.000 abstract 1
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
- G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
- G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO5736A AUPO573697A0 (en) | 1997-03-20 | 1997-03-20 | Diagnosis of endometrial cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY119567A true MY119567A (en) | 2005-06-30 |
Family
ID=3800039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI98001218A MY119567A (en) | 1997-03-20 | 1998-03-20 | Matrix metalloproteinase levels as indicators of endometrial cancer |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6607894B1 (enExample) |
| EP (1) | EP0979304B1 (enExample) |
| JP (2) | JP4183757B2 (enExample) |
| KR (1) | KR20010006344A (enExample) |
| CN (1) | CN1257550A (enExample) |
| AT (1) | ATE331039T1 (enExample) |
| AU (1) | AUPO573697A0 (enExample) |
| CA (1) | CA2284099C (enExample) |
| DE (1) | DE69835010T2 (enExample) |
| ES (1) | ES2268767T3 (enExample) |
| MY (1) | MY119567A (enExample) |
| NZ (1) | NZ337868A (enExample) |
| WO (1) | WO1998042865A1 (enExample) |
| ZA (1) | ZA982403B (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2322023A1 (en) * | 1998-03-05 | 1999-09-10 | John D. Burczak | A novel method of detecting and monitoring endometrial and uterine cancers |
| AUPQ219799A0 (en) | 1999-08-13 | 1999-09-02 | R. Lurie Pty Ltd | Apparatus for obtaining potological samples |
| US7094754B2 (en) | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US6906036B2 (en) | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US7071164B2 (en) | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
| US7186693B2 (en) | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
| DE10217677A1 (de) | 2002-04-19 | 2003-11-06 | Bayer Ag | Verwendung von Aufhellern zur Herstellung von Streichmassen |
| US7148194B2 (en) | 2002-12-30 | 2006-12-12 | Kimberly-Clark Worldwide, Inc. | Method to increase fibronectin |
| US7189700B2 (en) | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
| US20060003391A1 (en) * | 2003-08-11 | 2006-01-05 | Ring Brian Z | Reagents and methods for use in cancer diagnosis, classification and therapy |
| US20050112622A1 (en) * | 2003-08-11 | 2005-05-26 | Ring Brian Z. | Reagents and methods for use in cancer diagnosis, classification and therapy |
| ATE463743T1 (de) * | 2004-07-23 | 2010-04-15 | Ct De Rech Public De La Sante | Überwachung von herzversagen |
| US20080131916A1 (en) * | 2004-08-10 | 2008-06-05 | Ring Brian Z | Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy |
| US20060177448A1 (en) * | 2005-02-09 | 2006-08-10 | Genentech, Inc. | Inhibiting HER2 shedding with matrix metalloprotease antagonists |
| WO2007086915A2 (en) * | 2005-05-12 | 2007-08-02 | Applied Genomics, Inc. | Reagents and methods for use in cancer diagnosis, classification and therapy |
| RU2304782C1 (ru) * | 2005-12-28 | 2007-08-20 | Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова | Способ прогнозирования рецидива эндометриоидной кисты яичника |
| US8592393B2 (en) | 2007-11-02 | 2013-11-26 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| WO2009059284A2 (en) | 2007-11-02 | 2009-05-07 | Momenta Pharmaceuticals, Inc. | Non-anticoagulant polysaccharide compositions |
| US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| US20120183976A1 (en) * | 2009-04-16 | 2012-07-19 | He Zhou | Methods of assessing activity of a polysaccharide composition |
| DK2456889T3 (en) | 2009-07-24 | 2014-12-01 | Geadic Biotec Aie | Markers of endometrial cancer |
| JP5982361B2 (ja) | 2010-04-16 | 2016-08-31 | モメンタ ファーマシューティカルズ インコーポレイテッド | 組織標的化方法 |
| RU2430371C1 (ru) * | 2010-04-26 | 2011-09-27 | Учреждение Российской академии наук Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН) | Способ дифференциальной диагностики и прогноза миомы и рака эндометрия |
| CA2795868A1 (en) | 2010-06-17 | 2011-12-22 | Momenta Pharmaceuticals, Inc. | Methods and compositions for modulating hair growth |
| AU2012261953A1 (en) * | 2011-06-03 | 2013-12-12 | University Of South Alabama | Methods and compositions for detecting endometrial or ovarian cancer |
| WO2013044187A2 (en) * | 2011-09-22 | 2013-03-28 | Memorial Sloan-Kettering Cancer Center | Detecting ovarian cancer |
| PL2809801T3 (pl) * | 2012-01-31 | 2018-12-31 | SPEISER, Paul | Nieinwazyjna diagnoza raka |
| US10016449B2 (en) | 2013-05-28 | 2018-07-10 | Momenta Pharmaceuticals, Inc. | Pharmaceutical compositions |
| WO2016000028A1 (en) * | 2014-07-02 | 2016-01-07 | Bionomics Limited | Predictive biomarkers |
| WO2016127067A1 (en) * | 2015-02-06 | 2016-08-11 | Quest Diagnostics Investments Incorporated | Compositions and methods for determining endometrial cancer prognosis |
| CA3286798A1 (en) * | 2016-05-04 | 2025-10-30 | Fundacio Hospital Universitari Vall D'hebron-Institut De Recerca | Markers of endometrial cancer |
| IN202021002695A (enExample) | 2020-01-21 | 2021-07-23 | ||
| CN112961921B (zh) * | 2021-03-26 | 2022-07-01 | 中国医学科学院北京协和医院 | 一种用于判断早期子宫内膜癌预后的制剂及复发风险模型 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3940793A (en) * | 1992-03-31 | 1993-11-08 | Research Foundation Of The State University Of New York, The | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5280106A (en) * | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
| WO1994005807A1 (en) * | 1992-08-28 | 1994-03-17 | Dickson Robert B | Matrix-degrading metalloproteinase |
| EP0674710B1 (en) * | 1992-11-16 | 2003-05-02 | Cancer Research Fund Of Contra Costa | Peptides with broad neoplastic specificity |
-
1997
- 1997-03-20 AU AUPO5736A patent/AUPO573697A0/en not_active Abandoned
-
1998
- 1998-03-20 CA CA2284099A patent/CA2284099C/en not_active Expired - Fee Related
- 1998-03-20 ZA ZA982403A patent/ZA982403B/xx unknown
- 1998-03-20 US US09/381,454 patent/US6607894B1/en not_active Expired - Fee Related
- 1998-03-20 CN CN98805312A patent/CN1257550A/zh active Pending
- 1998-03-20 KR KR1019997009429A patent/KR20010006344A/ko not_active Withdrawn
- 1998-03-20 ES ES98909221T patent/ES2268767T3/es not_active Expired - Lifetime
- 1998-03-20 JP JP54453698A patent/JP4183757B2/ja not_active Expired - Fee Related
- 1998-03-20 WO PCT/AU1998/000189 patent/WO1998042865A1/en not_active Ceased
- 1998-03-20 MY MYPI98001218A patent/MY119567A/en unknown
- 1998-03-20 AT AT98909221T patent/ATE331039T1/de not_active IP Right Cessation
- 1998-03-20 DE DE69835010T patent/DE69835010T2/de not_active Expired - Lifetime
- 1998-03-20 NZ NZ337868A patent/NZ337868A/en not_active IP Right Cessation
- 1998-03-20 EP EP98909221A patent/EP0979304B1/en not_active Expired - Lifetime
-
2007
- 2007-01-09 JP JP2007001867A patent/JP2007202556A/ja not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3940793A (en) * | 1992-03-31 | 1993-11-08 | Research Foundation Of The State University Of New York, The | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
Non-Patent Citations (2)
| Title |
|---|
| AM.J.OBSTET.GYNECOL., VOL 171, NO 2, AUGUST 1994 K. TAMAKOSHI ET AL, PP 478-484 * |
| NIPPON SANKA FUJINKA GAKKAI ZASSHI-ACTA OBSTETRICA ET GYNAE COLOGICA JAPONICA, VOL 48 NO 8, AUGUST 1996 PP 618-622 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2284099C (en) | 2010-04-27 |
| CN1257550A (zh) | 2000-06-21 |
| EP0979304A1 (en) | 2000-02-16 |
| AUPO573697A0 (en) | 1997-04-10 |
| EP0979304A4 (en) | 2003-06-11 |
| ZA982403B (en) | 1998-10-21 |
| US6607894B1 (en) | 2003-08-19 |
| EP0979304B1 (en) | 2006-06-21 |
| ES2268767T3 (es) | 2007-03-16 |
| ATE331039T1 (de) | 2006-07-15 |
| JP2007202556A (ja) | 2007-08-16 |
| WO1998042865A1 (en) | 1998-10-01 |
| JP2002501613A (ja) | 2002-01-15 |
| DE69835010D1 (de) | 2006-08-03 |
| KR20010006344A (ko) | 2001-01-26 |
| NZ337868A (en) | 2002-05-31 |
| DE69835010T2 (de) | 2007-06-06 |
| CA2284099A1 (en) | 1998-10-01 |
| JP4183757B2 (ja) | 2008-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY119567A (en) | Matrix metalloproteinase levels as indicators of endometrial cancer | |
| GB2202328B (en) | Method for assaying nucleic acids, reagent combination and kit therefor | |
| FI953445A0 (fi) | Menetelmä nukleiinihappojen herkkään osoitukseen | |
| DE69931910D1 (en) | Pränatales screening für downs-syndrom | |
| HK1040533A1 (zh) | 监察蛋白脢体抑制剂药物活动的方法 | |
| EP1927362A3 (en) | Alphavbeta3integrin as a predictor of endometriosis | |
| FI915150A7 (fi) | Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi | |
| ES8609472A1 (es) | Una sonda de deteccion de acidos nucleicos | |
| GB9621129D0 (en) | Detecting genetic predisposition to sight-threatening diabetic retinopathy | |
| ATE107705T1 (de) | Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten. | |
| IL81695A (en) | Quantitative determination of the degree of amplification of genes and/or corresponding messenger rna and reagent kit for performing the determination | |
| ATE199025T1 (de) | Test zur diagnose eines erhöhten brustkrebs- risikos | |
| DE3264721D1 (en) | Reagent for assaying hydrogen peroxide and method of quantitative assay for hydrogen peroxide | |
| KR960702770A (ko) | 귀금속 및 실리카-알루미나를 주성분으로 하는 촉매 및 중질 공급물을 수소 이성질체화시키는 방법(noble metal-and silica/alumina-based catalyst and method for the hydroisomerisation processing of heavy feedstocks) | |
| FI854627A7 (fi) | Menetelmä ja reagenssi plasmassa, seerumissa tai kokoveressä olevan vapaan tyroksiinin kvantitatiiviseksi määrittämiseksi. | |
| DK0791073T3 (da) | Analysemetode | |
| FR2791141B1 (fr) | Procede de reduction de l'extinction de fluorescence due au milieu de mesure | |
| WO1999054707A3 (en) | Fetal testing for prediction of low birth weight | |
| EP0158224A3 (en) | Analysis method and means for detecting esterolytic and/or proteolytic enzymes | |
| BR0007056A (pt) | Enzima mutante produtora de nucleosìdeo-5' -fosfato, métodos para a produção de uma enzima mutante produtora de nucleosìdeo-5' -fosfato, de um inibidor para uma enzima fosfatase ou de transfosforilação e de um nucleosìdeo-5' -fosfato, cristais de uma enzima, de fosfatase ácida e de complexo de fosfatase ácida, gene, dna recombinante, e, microorganismo | |
| PT800085E (pt) | Rastreio pre-natal para sindrome de down | |
| DE3572511D1 (en) | Analysis method and means for detecting esterolytic and or proteolytic enzymes | |
| Africa | An act (No. 92 of 1996) to determine the circumstances in which and conditions under which the pregnancy of a woman may be terminated; and to provide for matters connected therewith. Date of assent: 12 Nov 1996.(The Choice on Termination of Pregnancy Act, 1996).(Government Gazette, 22 Nov 1996, Vol 377, No. 17602, pp. 1-10) | |
| UA28557A (uk) | Спосіб визначення величини фетоматеринської трансфузії | |
| DE69314633D1 (de) | Methoden und Zusammensetzungen um die Sensitivität eine Zellegegen DNA-Zerstörende Agentien zu erhöhen |